ESMO Melanoma Faculty Coordinator Olivier Michielin discusses the CheckMate 238, COMBI-AD, and BRIM8 trials presented at the third Presidential symposium.
20-09-2017 | Melanoma | ESMO 2017 | Video
20-09-2017 | Melanoma | ESMO 2017 | Video
ESMO Melanoma Faculty Coordinator Olivier Michielin discusses the CheckMate 238, COMBI-AD, and BRIM8 trials presented at the third Presidential symposium.